Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer
Francisco José Cândido dos Reis(Universidade de São Paulo), Brooke L. Fridley(Children's Mercy Hospital), Julie M. Cunningham(Cancer Research UK), Weiva Sieh(The University of Texas MD Anderson Cancer Center), Elisa Alducci(Istituto Oncologico Veneto), Allan Jensen(Danish Cancer Society), Charlie Gourley(Edinburgh Cancer Research), Ellen L. Goode(Mayo Clinic in Arizona), Honglin Song(University of Cambridge), Ava Kwong(University of Hong Kong), Jennifer T. Loud(National Cancer Institute), Kathryn Alsop(Peter MacCallum Cancer Centre), Estrid Høgdall(University of Copenhagen), Kelly L. Bolton(Washington University in St. Louis), Susanne K. Kjær(Copenhagen University Hospital), Caroline O. Michie(Ninewells Hospital), Alice S. Whittemore(Cancer Registry of Norway), Marco Montagna(Azienda Ospedale - Università Padova), Robert L. Nussbaum(National Institutes of Health), Amanda E. Toland(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Susan J. Ramus(Cancer Institute of New South Wales), Irene L. Andrulis(University of Toronto), Ed Dicks(Institute of Cancer Research), Javier Benı́tez(Spanish National Cancer Research Centre), Anna Marie Mulligan, Christine Walsh(Cedars-Sinai Medical Center), Sián Fereday(Peter MacCallum Cancer Centre), Gord Glendon(University Health Network), Susan L. Neuhausen(City of Hope), Valerie McGuire(Cargill (Netherlands)), Conxi Lázaro(Institut d'Investigació Biomédica de Bellvitge), Siegal Sadetzki(Tel Aviv University), Ilana Cass(Cedars-Sinai Medical Center), Ignacio Blanco(Hospital Universitari Germans Trias i Pujol), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Beth Y. Karlan(University of California, Los Angeles), Mark H. Greene(Cancer Institute (WIA)), María J. García(Spanish National Cancer Research Centre), Melissa C. Larson(Mayo Clinic), Kirsten Moysich(Roswell Park Comprehensive Cancer Center), Patricia Harrington(Roswell Park Comprehensive Cancer Center), Angela Chetrit(Sheba Medical Center), Mary B. Daly(Fox Chase Cancer Center), Jenny Lester(Cedars-Sinai Medical Center), Anna de Fazio(Millennium Institute), Gillian Mitchell(Peter MacCallum Cancer Centre), Håkan Olsson(Nokia (Finland)), Martin Gore(Imperial College London)
Cited by 160
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <i>BRCA1/2</i> Mutation
|Journal of Clinical Oncology|2014|1.7k